Aptamers are nucleic acid ligands selected to interact with specific proteins with high affinity. In the 5 September
Rusconi
This strategy presents a promising approach for the development of safe aptamer-antidote pairs as therapeutics.
Aptamers are nucleic acid ligands selected to interact with specific proteins with high affinity. In the 5 September
Rusconi
This strategy presents a promising approach for the development of safe aptamer-antidote pairs as therapeutics.